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INTRODUCTION
Trans-rectal ultrasound-guided Prostate Needle Biopsy (PNBx) is the diagnostic practice of choice for prostate cancer (PCa) detection; it is considered a safe and routinely procedure, with a low risk of major complications requiring hospital admission (1), as fever and sepsis. Minor complications, such as rectal bleeding, acute urinary retention, hematospermia and hematuria are relatively frequent but usually self-limiting (2, 3) . Besides this well-documented side-effects, an increasing number of articles is showing a possible role of PNBx to cause Erectile Dysfunction (ED) (4-6). Some studies described this effect as temporary (7) (8) (9) , and attributed to anxiety (9) rather than a real organic injury (6) . Moreover, this studies often investigated Erectile Function (EF) in patients on active surveillance, that is to say with a diagnosis of prostate cancer, a potential negative psychological confounder that may influence their EF (10) . Another cohort of men who underwent to seriate PNBx is that of patients with diagnosis of Atypical small acinar proliferation (ASAP), a kind of precancerous lesion considered to be an element in the progression of changes in cell morphology between healthy tissue of the prostate and PCa (11) . Furthermore, due to the opinion that at least some cases of ASAP diagnosis in biopsy specimens are actually undiagnosed cancers (12) , the indication to second biopsy in such patients has been commonly accepted (11, 13) . To the best of our knowledge, no study has investigated the impact on EF of seriate PNBx done in patients with diagnosis of ASAP; in the current article, we analyzed this aspect and evaluated if ecocolorDoppler can help to prevent this side effect (Figure 1 ).
MATERIALS AND METHODS
This retrospective study includes 190 men with a diagnosis of ASAP detected between January 2001 and December 2011 and undergone to repeated PNBx. Baseline EF was evaluated before the first biopsy using International Index of Erectile Function (IIEF-5) questionnaire; by the obtained score the patients were stratified in 5 groups ( Figure 2 ). According to the literature, patients belonging to Group 1 (defined by an IIEF-5 score > 21), were considered having a normal EF. In order to complete the study of the patients it was also investigated the preexistence of Lower Urinary Tract Symptoms (LUTS) by using International Prostate Symptom Score (IPSS). Regarding the procedure, after quinolone chemoprophylaxis and local anesthesia, it was managed a 12-16 core transrectal biopsy using a Tru Cut Cook 18G needle under transrectal uiltrasound (TRUS) control. In particular, in the group 1 of 89 patients ( Figure 2 ) not affected by ED (defined by an IIEF-5 score < 22) before the first PNBx, 64 patients underwent to standard transrectal biopsies; whereas in a subgroup of 25 Power Doppler evaluation was added to the standard ultrasonography imaging to better identify neurovascular bundles (NVBs) and avoid them with the needle.
A comparison of IIEF-5 and IPSS score submitted before and 3 months after PNBx was performed to analyze differences between baseline and follow-up IIEF-5 scores, and eventually the relation with the number of PNBx done. T Student's test was used; a p value < 0.05 was considered statistically significant.
RESULTS
Patients who were analyzed in this study resulted to have a mean age of 65 years (SD 7.7); their mean follow-up was 3,2 years (SD 1.8) and the mean number of re-biopsies was 2 (SD 1.5). Among the 143 men who concluded the follow up, only 89 resulted with a normal EF (corresponding to an IIEF-5 score > 21): in this group incidence of ED (IIEF-5 score < 21) among patients who underwent to standard PNBx was 4/64 (6.25%) while in patients submitted to a PNBx with ECD was 1/25 (4%). Univariate analysis was performed to compare the variation in IIEF-5 score (considered as the difference between the baseline IIEF and the IIEF-5 at the last follow up) in men without previous ED who underwent to repeated PNBx: the p value for this difference was < 0.001, showing a significant correlation between repeated PNBx and EF as illustrated in Figure 3 .
Moreover, the variation of the IIEF-5 score in patients who underwent 0 to 2 re-PNBx resulted significantly lower than in men who underwent more than 2 re-PNBx (p < 0.05), demonstrating a relationship with the number of PNBx done. On the other hand, no significant worsening of IPSS score was identified after re-PNBx, with only temporary irritative urinary symptoms reported by some patients.
DISCUSSION
So far is not clearly defined by the international literature whether serial PNBx predispose to a permanent ED over time: nevertheless only few studies, as the one leaded by Hilton et al., showed a total absence of correlation between this side effect and the procedure (14). In the majority of the examined studies, the investigators demonstrated a short-term (30 days) impact on EF, asso- ciated to psychological factors as anxiety and diagnosis of PCa (8, 10) rather than to use of periprostatic nerve block and flogosis linked to the procedure. Some authors considered PNBx follow-up at 1 and 6 months: Akbal et al showed a worsened EF 1 month after PNBx that returns at baseline level at 6 months (3): in this study the authors analyzed specifically only PCa-free patients, avoiding bias due to the cancer detection. Tuncel et al. described an high number of patients (up to 41%) without ED that developed a deterioration of EF one month after PNBx: 6 months later 15% still had ED, demonstrating a significant correlation between PNBx and ED (4). Recently, another article of Tuncel showed that the association between PNBx and DE might have an organic basis, demonstrating with power Doppler ultrasonography an inflammation of the prostate parenchyma and of the surrounding neurovascular bundle in patients suffering from ED after PNBx (6) . This last article, may give a possible explication of the utility, described in our study, to add Power Doppler to the standard ultrasonography imaging, to better identify neurovascular bundles (NVBs), and avoid them with the needle. This care towards the bundles has become nowadays more and more important in consideration to the increase of the number of cores taken in each PNBx such as the practice of submit patients to repeated PNBx.
CONCLUSIONS
Men with diagnosis of ASAP who uunderwent to repeated PNBx are at risk of worsening EF; this risk appears to grow with the increase of biopsy number. Furthermore, this study proposes the use of ECD in transrectal ultrasoundguided PNBx with the purpose to avoid neurovascular bundles (NVBs) and preserve EF; nevertheless additional studies are highly suggested to validate this hypothesis.
